✦ LIBER ✦

A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy

✍ Scribed by Sampson, Hugh A.; Leung, Donald Y.M.; Burks, A. Wesley; Lack, Gideon; Bahna, Sami L.; Jones, Stacie M.; Wong, Dennis A.

Book ID: 119285201
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 60 KB
Volume: 127
Category: Article
ISSN: 1097-6825
DOI: 10.1016/j.jaci.2011.01.051

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II, Randomized, Double-Blind, Pa

A Phase II, Randomized, Double-Blind, Parallel-group, Placebo-Controlled, Oral Food Challenge Trial of XOLAIR® (omalizumab) in Peanut Allergy (TOPS)

✍ Sampson, H.A. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Efficacy and safety of solifenacin succi

Efficacy and safety of solifenacin succinate 10 mg once Daily: A multicenter, phase III, randomized, double-blind, placebo-controlled, parallel-group trial in patients with overactive bladder

✍ Franklin Chu; Neila Smith; Takeshi Uchida 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Efficacy and safety of oral SK3530 for t

Efficacy and safety of oral SK3530 for the treatment of erectile dysfunction in Korean men: a multicenter, randomized, double-blind, placebo-controlled, fixed dose, parallel group clinical trial

✍ Jae-Seung Paick; Hyung-Ki Choi; Sae-Chul Kim; Tai-Young Ahn; Je-Jong Kim; Jong-K 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 493 KB

Safety and efficacy of ocrelizumab in pa

Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a forty-eight–week randomized, double-blind, placebo-controlled, parallel-group phase III trial

✍ W. Rigby; H.-P. Tony; K. Oelke; B. Combe; A. Laster; C. A. von Muhlen; E. Fishel 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

Safety Profile and Metabolic Effects of

Safety Profile and Metabolic Effects of 14 Days of Treatment with DIO-902: Results of a Phase IIa Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial in Patients with Type 2 Diabetes Mellitus

✍ Sherwyn L. Schwartz; Marc Rendell; Andrew J. Ahmann; Asha Thomas; Carlos J. Arau 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 118 KB

A randomized, double-blind, four-arm par

A randomized, double-blind, four-arm parallel-group, placebo-controlled Phase II/III study to investigate the clinical efficacy of two galenic formulations of Polyphenon® E in the treatment of external genital warts

✍ G Gross; K-G Meyer; H Pres; C Thielert; H Tawfik; A Mescheder 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB